<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26694452</PMID><DateCompleted><Year>2016</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>12</Issue><PubDate><Year>2015</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Glucose-6-Phosphate Dehydrogenase Enhances Antiviral Response through Downregulation of NADPH Sensor HSCARG and Upregulation of NF-&#x3ba;B Signaling.</ArticleTitle><Pagination><StartPage>6689</StartPage><EndPage>6706</EndPage><MedlinePgn>6689-706</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/v7122966</ELocationID><Abstract><AbstractText>Glucose-6-phosphate dehydrogenase (G6PD)-deficient cells are highly susceptible to viral infection. This study examined the mechanism underlying this phenomenon by measuring the expression of antiviral genes-tumor necrosis factor alpha (TNF-&#x3b1;) and GTPase myxovirus resistance 1 (MX1)-in G6PD-knockdown cells upon human coronavirus 229E (HCoV-229E) and enterovirus 71 (EV71) infection. Molecular analysis revealed that the promoter activities of TNF-&#x3b1; and MX1 were downregulated in G6PD-knockdown cells, and that the I&#x3ba;B degradation and DNA binding activity of NF-&#x3ba;B were decreased. The HSCARG protein, a nicotinamide adenine dinucleotide phosphate (NADPH) sensor and negative regulator of NF-&#x3ba;B, was upregulated in G6PD-knockdown cells with decreased NADPH/NADP&#x207a; ratio. Treatment of G6PD-knockdown cells with siRNA against HSCARG enhanced the DNA binding activity of NF-&#x3ba;B and the expression of TNF-&#x3b1; and MX1, but suppressed the expression of viral genes; however, the overexpression of HSCARG inhibited the antiviral response. Exogenous G6PD or IDH1 expression inhibited the expression of HSCARG, resulting in increased expression of TNF-&#x3b1; and MX1 and reduced viral gene expression upon virus infection. Our findings suggest that the increased susceptibility of the G6PD-knockdown cells to viral infection was due to impaired NF-&#x3ba;B signaling and antiviral response mediated by HSCARG.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yi-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Tao-yuan 333, Taiwan. yihsuanwu@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Daniel Tsun-Yee</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Tao-yuan 333, Taiwan. dtychiu@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Aging Research Center, Chang Gung University, Tao-yuan 333, Taiwan. dtychiu@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Chang Gung Memorial Hospital, Lin-Kou 333, Taiwan. dtychiu@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Hsin-Ru</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Molecular Medicine Research Center, Chang Gung University, Tao-yuan 333, Taiwan. rebecca19852006@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Hsiang-Yu</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Healthy Aging Research Center, Chang Gung University, Tao-yuan 333, Taiwan. tangshyu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Tao-yuan 333, Taiwan. chengm@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Aging Research Center, Chang Gung University, Tao-yuan 333, Taiwan. chengm@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, College of Medicine, Chang Gung University, Tao-yuan 333, Taiwan. chengm@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Hung-Yao</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Tao-yuan 333, Taiwan. hoh01@mail.cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthy Aging Research Center, Chang Gung University, Tao-yuan 333, Taiwan. hoh01@mail.cgu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579071">MX1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064547">Myxovirus Resistance Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C520476">NMRAL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.1.1.49</RegistryNumber><NameOfSubstance UI="D005954">Glucosephosphate Dehydrogenase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028941" MajorTopicYN="N">Coronavirus 229E, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005954" MajorTopicYN="N">Glucosephosphate Dehydrogenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064547" MajorTopicYN="N">Myxovirus Resistance Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">G6PD</Keyword><Keyword MajorTopicYN="N">HSCARG</Keyword><Keyword MajorTopicYN="N">NADPH</Keyword><Keyword MajorTopicYN="N">antiviral response</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26694452</ArticleId><ArticleId IdType="pmc">PMC4690889</ArticleId><ArticleId IdType="doi">10.3390/v7122966</ArticleId><ArticleId IdType="pii">v7122966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ho H.Y., Cheng M.L., Chiu D.T. Glucose-6-phosphate dehydrogenase&#x2014;Beyond the realm of red cell biology. Free Radic. Res. 2014;48:1028&#x2013;1048. doi: 10.3109/10715762.2014.913788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2014.913788</ArticleId><ArticleId IdType="pubmed">24720642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Chiu D.T. G6PD&#x2014;An old bottle with new wine. Chang Gung Med. J. 2005;28:606&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">16323551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.L., Ho H.Y., Liang C.M., Chou Y.H., Stern A., Lu F.J., Chiu D.T. Cellular glucose-6-phosphate dehydrogenase (G6PD) status modulates the effects of nitric oxide (NO) on human foreskin fibroblasts. FEBS Lett. 2000;475:257&#x2013;262. doi: 10.1016/S0014-5793(00)01687-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(00)01687-2</ArticleId><ArticleId IdType="pubmed">10869567</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L.P., Cheng M.L., Chou H.J., Yang Y.H., Ho H.Y., Chiu D.T. Ineffective GSH regeneration enhances G6PD-knockdown Hep G2 cell sensitivity to diamide-induced oxidative damage. Free Radic. Biol. Med. 2009;47:529&#x2013;535. doi: 10.1016/j.freeradbiomed.2009.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.05.029</ArticleId><ArticleId IdType="pubmed">19497363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Lu F.J., Chou Y.H., Stern A., Liang C.M., Chiu D.T. Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts. Free Radic. Biol. Med. 2000;29:156&#x2013;169. doi: 10.1016/S0891-5849(00)00331-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00331-2</ArticleId><ArticleId IdType="pubmed">10980404</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.J., Ho H.Y., Cheng M.L., You T.H., Yu J.S., Chiu D.T. Impaired dephosphorylation renders G6PD-knockdown HepG2 cells more susceptible to H2O2-induced apoptosis. Free Radic. Biol. Med. 2010;49:361&#x2013;373. doi: 10.1016/j.freeradbiomed.2010.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.04.019</ArticleId><ArticleId IdType="pubmed">20420899</ArticleId></ArticleIdList></Reference><Reference><Citation>Arese P., de Flora A. Pathophysiology of hemolysis in glucose-6-phosphate dehydrogenase deficiency. Semin. Hematol. 1990;27:1&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">2405494</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirdah M., Reading N.S., Perkins S.L., Shubair M., Aboud L., Prchal J.T. Hemolysis and Mediterranean G6PD mutation (c.563 C&gt;T) and c.1311 C&gt;T polymorphism among Palestinians at Gaza Strip. Blood Cells Mol. Dis. 2012;48:203&#x2013;208. doi: 10.1016/j.bcmd.2012.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2012.01.007</ArticleId><ArticleId IdType="pubmed">22364808</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskin R.S., Estwick D., Peddi R. G6PD deficiency: Its role in the high prevalence of hypertension and diabetes mellitus. Ethn. Dis. 2001;11:749&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">11763298</ArticleId></ArticleIdList></Reference><Reference><Citation>Meloni T., Pacifico A., Forteleoni G., Meloni G.F. G6PD deficiency and diabetes mellitus in northern Sardinian subjects. Haematologica. 1992;77:94&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">1398291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hecker P.A., Leopold J.A., Gupte S.A., Recchia F.A., Stanley W.C. Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2013;304:H491&#x2013;H500. doi: 10.1152/ajpheart.00721.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00721.2012</ArticleId><ArticleId IdType="pmc">PMC3566485</ArticleId><ArticleId IdType="pubmed">23241320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan G.H., Tsai S.C., Chiu D.T. Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine. 2002;19:191&#x2013;195. doi: 10.1385/ENDO:19:2:191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/ENDO:19:2:191</ArticleId><ArticleId IdType="pubmed">12588050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Weng S.F., Chang L., Yeh T.T., Shih S.R., Chiu D.T. Glucose-6-phosphate dehydrogenase deficiency enhances Enterovirus 71 infection. J. Gen. Virol. 2008;89:2080&#x2013;2089. doi: 10.1099/vir.0.2008/001404-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.2008/001404-0</ArticleId><ArticleId IdType="pubmed">18753216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y.H., Tseng C.P., Cheng M.L., Ho H.Y., Shih S.R., Chiu D.T. Glucose-6-phosphate dehydrogenase deficiency enhances human Coronavirus 229E infection. J. Infect. Dis. 2008;197:812&#x2013;816. doi: 10.1086/528377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/528377</ArticleId><ArticleId IdType="pmc">PMC7199897</ArticleId><ArticleId IdType="pubmed">18269318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao Y.C., Huang C.S., Lee C.N., Chang S.Y., King C.C., Kao C.L. Higher infection of Dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PLoS ONE. 2008;3: doi: 10.1371/journal.pone.0001557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0001557</ArticleId><ArticleId IdType="pmc">PMC2216061</ArticleId><ArticleId IdType="pubmed">18270558</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodbourn S., Didcock L., Randall R.E. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000;81:2341&#x2013;2364. doi: 10.1099/0022-1317-81-10-2341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-81-10-2341</ArticleId><ArticleId IdType="pubmed">10993923</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadden G., Mohamed M.R., Rahman M.M., Bartee E. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 2009;9:645&#x2013;655. doi: 10.1038/nri2623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2623</ArticleId><ArticleId IdType="pmc">PMC4373421</ArticleId><ArticleId IdType="pubmed">19696766</ArticleId></ArticleIdList></Reference><Reference><Citation>Matikainen S., Siren J., Tissari J., Veckman V., Pirhonen J., Severa M., Sun Q., Lin R., Meri S., Uze G., et al. Tumor necrosis factor &#x3b1; enhances influenza A virus-induced expression of antiviral cytokines by activating RIG-I gene expression. J. Virol. 2006;80:3515&#x2013;3522. doi: 10.1128/JVI.80.7.3515-3522.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.80.7.3515-3522.2006</ArticleId><ArticleId IdType="pmc">PMC1440408</ArticleId><ArticleId IdType="pubmed">16537619</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartee E., Mohamed M.R., McFadden G. Tumor necrosis factor and interferon: Cytokines in harmony. Curr. Opin. Microbiol. 2008;11:378&#x2013;383. doi: 10.1016/j.mib.2008.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2008.05.015</ArticleId><ArticleId IdType="pmc">PMC7108444</ArticleId><ArticleId IdType="pubmed">18595771</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008;8:559&#x2013;568. doi: 10.1038/nri2314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2314</ArticleId><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Justesen J., Hartmann R., Kjeldgaard N.O. Gene structure and function of the 2&#x2032;-5&#x2032;-oligoadenylate synthetase family. Cell Mol. Life Sci. 2000;57:1593&#x2013;1612. doi: 10.1007/PL00000644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00000644</ArticleId><ArticleId IdType="pmc">PMC11146851</ArticleId><ArticleId IdType="pubmed">11092454</ArticleId></ArticleIdList></Reference><Reference><Citation>Malathi K., Paranjape J.M., Bulanova E., Shim M., Guenther-Johnson J.M., Faber P.W., Eling T.E., Williams B.R., Silverman R.H. A transcriptional signaling pathway in the IFN system mediated by 2&#x2032;-5&#x2032;-oligoadenylate activation of RNAse L. Proc. Natl. Acad. Sci. USA. 2005;102:14533&#x2013;14538. doi: 10.1073/pnas.0507551102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0507551102</ArticleId><ArticleId IdType="pmc">PMC1239948</ArticleId><ArticleId IdType="pubmed">16203993</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhelst J., Parthoens E., Schepens B., Fiers W., Saelens X. Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J. Virol. 2012;86:13445&#x2013;13455. doi: 10.1128/JVI.01682-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01682-12</ArticleId><ArticleId IdType="pmc">PMC3503048</ArticleId><ArticleId IdType="pubmed">23015724</ArticleId></ArticleIdList></Reference><Reference><Citation>Elde N.C., Child S.J., Eickbush M.T., Kitzman J.O., Rogers K.S., Shendure J., Geballe A.P., Malik H.S. Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses. Cell. 2012;150:831&#x2013;841. doi: 10.1016/j.cell.2012.05.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.05.049</ArticleId><ArticleId IdType="pmc">PMC3499626</ArticleId><ArticleId IdType="pubmed">22901812</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., Birdwell L.D., Wu A., Elliott R., Rose K.M., Phillips J.M., Li Y., Grinspan J., Silverman R.H., Weiss S.R. Cell-type-specific activation of the oligoadenylate synthetase-RNAse l pathway by a murine coronavirus. J. Virol. 2013;87:8408&#x2013;8418. doi: 10.1128/JVI.00769-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00769-13</ArticleId><ArticleId IdType="pmc">PMC3719824</ArticleId><ArticleId IdType="pubmed">23698313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzitto J., Galligan C.L., Ueng J.J., Fish E.N. Characterization of the antiviral effects of interferon-&#x3b1; against a SARS-like coronoavirus infection in vitro. Cell Res. 2006;16:220&#x2013;229. doi: 10.1038/sj.cr.7310030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.cr.7310030</ArticleId><ArticleId IdType="pmc">PMC7091892</ArticleId><ArticleId IdType="pubmed">16474437</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong W.F., Tan H.C., Ooi E.E., Koh D.R., Chow V.T. Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells. Microbes Infect. 2005;7:248&#x2013;259. doi: 10.1016/j.micinf.2004.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2004.11.004</ArticleId><ArticleId IdType="pmc">PMC7110627</ArticleId><ArticleId IdType="pubmed">15777647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M., Iwasaki T., Yoshikawa T., Nagata N., Sato Y., Sata T., Yoneyama M., Fujita T., Taya C., Yonekawa H., et al. The &#x3b1;/&#x3b2; interferon response controls tissue tropism and pathogenicity of poliovirus. J. Virol. 2005;79:4460&#x2013;4469. doi: 10.1128/JVI.79.7.4460-4469.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.Y., Solomon D.H. Tumor necrosis factor blockade and the risk of viral infection. Nat. Rev. Rheumatol. 2010;6:165&#x2013;174. doi: 10.1038/nrrheum.2009.279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2009.279</ArticleId><ArticleId IdType="pmc">PMC3155180</ArticleId><ArticleId IdType="pubmed">20142812</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfadda A.A., Sallam R.M. Reactive oxygen species in health and disease. J. Biomed. Biotechnol. 2012;2012:936486. doi: 10.1155/2012/936486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/936486</ArticleId><ArticleId IdType="pmc">PMC3424049</ArticleId><ArticleId IdType="pubmed">22927725</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeger G., Quiney C., Cotter T.G. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid. Redox Signal. 2009;11:2655&#x2013;2671. doi: 10.1089/ars.2009.2728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2728</ArticleId><ArticleId IdType="pubmed">19558209</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol. Rev. 2007;87:245&#x2013;313. doi: 10.1152/physrev.00044.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00044.2005</ArticleId><ArticleId IdType="pubmed">17237347</ArticleId></ArticleIdList></Reference><Reference><Citation>Rada B., Leto T.L. Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol. 2008;15:164&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2776633</ArticleId><ArticleId IdType="pubmed">18511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandvaux N., Soucy-Faulkner A., Fink K. Innate host defense: Nox and Duox on phox&#x2019;s tail. Biochimie. 2007;89:1113&#x2013;1122. doi: 10.1016/j.biochi.2007.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2007.04.008</ArticleId><ArticleId IdType="pubmed">17537563</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolowschiak T., Chassin C., Ben Mkaddem S., Fuchs T.M., Weiss S., Vandewalle A., Hornef M.W. Potentiation of epithelial innate host responses by intercellular communication. PLoS Pathog. 2010;6: doi: 10.1371/journal.ppat.1001194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001194</ArticleId><ArticleId IdType="pmc">PMC2987820</ArticleId><ArticleId IdType="pubmed">21124989</ArticleId></ArticleIdList></Reference><Reference><Citation>Soucy-Faulkner A., Mukawera E., Fink K., Martel A., Jouan L., Nzengue Y., Lamarre D., Vande Velde C., Grandvaux N. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog. 2010;6: doi: 10.1371/journal.ppat.1000930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000930</ArticleId><ArticleId IdType="pmc">PMC2880583</ArticleId><ArticleId IdType="pubmed">20532218</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai X., Li Y., Meng G., Yao S., Zhao Y., Yu Q., Zhang J., Luo M., Zheng X. NADPH is an allosteric regulator of HSCARG. J. Mol. Biol. 2009;387:1277&#x2013;1285. doi: 10.1016/j.jmb.2009.02.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2009.02.049</ArticleId><ArticleId IdType="pubmed">19254724</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Dai X., Zhao Y., Chen Q., Lu F., Yao D., Yu Q., Liu X., Zhang C., Gu X., et al. Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein. Proc Natl Acad Sci USA. 2007;104:8809&#x2013;8814. doi: 10.1073/pnas.0700480104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0700480104</ArticleId><ArticleId IdType="pmc">PMC1885584</ArticleId><ArticleId IdType="pubmed">17496144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian M., Zheng X. HSCARG regulates NF-&#x3ba;B activation by promoting the ubiquitination of RelA or COMMD1. J. Biol. Chem. 2009;284:17998&#x2013;18006. doi: 10.1074/jbc.M809752200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M809752200</ArticleId><ArticleId IdType="pmc">PMC2709395</ArticleId><ArticleId IdType="pubmed">19433587</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Q., Li T., Hu B., Lian M., Zheng X. HSCARG inhibits activation of NF-&#x3ba;B by interacting with I&#x3ba;B kinase-&#x3b2;. J. Cell Sci. 2009;122 Pt 22:4081&#x2013;4088. doi: 10.1242/jcs.054007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.054007</ArticleId><ArticleId IdType="pubmed">19843583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M., Hu B., Li T., Peng Y., Guan J., Lai S., Zheng X. A CRM1-dependent nuclear export signal controls nucleocytoplasmic translocation of HSCARG, which regulates NF-&#x3ba;B activity. Traffic. 2012;13:790&#x2013;799. doi: 10.1111/j.1600-0854.2012.01346.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0854.2012.01346.x</ArticleId><ArticleId IdType="pubmed">22348310</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y., Xu R., Zheng X. HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB1. PLoS Pathog. 2014;10: doi: 10.1371/journal.ppat.1004041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004041</ArticleId><ArticleId IdType="pmc">PMC3999155</ArticleId><ArticleId IdType="pubmed">24763515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H.R., Wu C.C., Wu Y.H., Hsu C.W., Cheng M.L., Chiu D.T. Proteome-wide dysregulation by glucose-6-phosphate dehydrogenase (G6PD) reveals a novel protective role for G6PD in aflatoxin B(1)-mediated cytotoxicity. J. Proteome Res. 2013;12:3434&#x2013;3448. doi: 10.1021/pr4002959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr4002959</ArticleId><ArticleId IdType="pubmed">23742107</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Shiao M.S., Chiu D.T. Characterization of global metabolic responses of glucose-6-phosphate dehydrogenase-deficient hepatoma cells to diamide-induced oxidative stress. Free Radic. Biol. Med. 2013;54:71&#x2013;84. doi: 10.1016/j.freeradbiomed.2012.10.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.10.557</ArticleId><ArticleId IdType="pubmed">23142419</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho M.K., Jang Y.P., Kim Y.C., Kim S.G. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition: The role in TNF-&#x3b1; inhibition. Int. Immunopharmacol. 2004;4:1419&#x2013;1429. doi: 10.1016/j.intimp.2004.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2004.06.011</ArticleId><ArticleId IdType="pubmed">15313439</ArticleId></ArticleIdList></Reference><Reference><Citation>Holzinger D., Jorns C., Stertz S., Boisson-Dupuis S., Thimme R., Weidmann M., Casanova J.L., Haller O., Kochs G. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 2007;81:7776&#x2013;7785. doi: 10.1128/JVI.00546-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00546-06</ArticleId><ArticleId IdType="pmc">PMC1933351</ArticleId><ArticleId IdType="pubmed">17494065</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho H.Y., Cheng M.L., Chiu D.T. Glucose-6-phosphate dehydrogenase&#x2014;From oxidative stress to cellular functions and degenerative diseases. Redox Rep. 2007;12:109&#x2013;118. doi: 10.1179/135100007X200209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/135100007X200209</ArticleId><ArticleId IdType="pubmed">17623517</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisoncik J.R., Billharz R., Burmakina S., Belisle S.E., Proll S.C., Korth M.J., Garcia-Sastre A., Katze M.G. The NS1 protein of influenza A virus suppresses interferon-regulated activation of antigen-presentation and immune-proteasome pathways. J. Gen. Virol. 2011;92: doi: 10.1099/vir.0.84873-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.84873-0</ArticleId><ArticleId IdType="pmc">PMC3353386</ArticleId><ArticleId IdType="pubmed">21593271</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K., Tripathi S., Ranjan P., Kumar P., Garten R., Deyde V., Katz J.M., Cox N.J., Lal R.B., Sambhara S., et al. Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation. PLoS ONE. 2011;6: doi: 10.1371/journal.pone.0020215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020215</ArticleId><ArticleId IdType="pmc">PMC3115951</ArticleId><ArticleId IdType="pubmed">21698289</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G., Chen G., Zheng D., Cheng G., Tang H. PLP2 of mouse hepatitis virus A59 (MHV-A59) targets TBK1 to negatively regulate cellular type I interferon signaling pathway. PLoS ONE. 2011;6: doi: 10.1371/journal.pone.0017192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017192</ArticleId><ArticleId IdType="pmc">PMC3041802</ArticleId><ArticleId IdType="pubmed">21364999</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X., Pan J., Tao J., Guo D. SARS-CoV nucleocapsid protein antagonizes IFN-&#x3b2; response by targeting initial step of IFN-&#x3b2; induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes. 2011;42:37&#x2013;45. doi: 10.1007/s11262-010-0544-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-010-0544-x</ArticleId><ArticleId IdType="pmc">PMC7088804</ArticleId><ArticleId IdType="pubmed">20976535</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniak S., Owens A.P., 3rd, Baunacke M., Williams J.C., Lee R.D., Weithauser A., Sheridan P.A., Malz R., Luyendyk J.P., Esserman D.A., et al. PAR-1 contributes to the innate immune response during viral infection. J. Clin. Investig. 2013;123:1310&#x2013;1322. doi: 10.1172/JCI66125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI66125</ArticleId><ArticleId IdType="pmc">PMC3582138</ArticleId><ArticleId IdType="pubmed">23391721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendelja K., Vojvoda V., Aberle N., Cepin-Bogovic J., Gagro A., Mlinaric-Galinovic G., Rabatic S. Decreased Toll-like receptor 8 expression and lower TNF-&#x3b1; synthesis in infants with acute RSV infection. Respir. Res. 2010;11: doi: 10.1186/1465-9921-11-143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1465-9921-11-143</ArticleId><ArticleId IdType="pmc">PMC2974671</ArticleId><ArticleId IdType="pubmed">20946625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J., Grandvaux N., Sharma S., Tenoever B.R., Servant M.J., Lin R. Convergence of the NF-&#x3ba;B and interferon signaling pathways in the regulation of antiviral defense and apoptosis. Ann. N. Y. Acad. Sci. 2003;1010:237&#x2013;248. doi: 10.1196/annals.1299.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1299.042</ArticleId><ArticleId IdType="pubmed">15033728</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiscott J. Convergence of the NF-&#x3ba;B and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 2007;18:483&#x2013;490. doi: 10.1016/j.cytogfr.2007.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2007.06.002</ArticleId><ArticleId IdType="pubmed">17706453</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 2006;311:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">17048703</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro M.G., Rossi A., Amici C. NF-&#x3ba;B and virus infection: Who controls whom. EMBO J. 2003;22:2552&#x2013;2560. doi: 10.1093/emboj/cdg267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/cdg267</ArticleId><ArticleId IdType="pmc">PMC156764</ArticleId><ArticleId IdType="pubmed">12773372</ArticleId></ArticleIdList></Reference><Reference><Citation>Siomek A. NF-&#x3ba;B signaling pathway and free radical impact. Acta Biochim. Pol. 2012;59:323&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">22855720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb H.K., Stammers D.K., Hawkins A.R. Dinucleotide-sensing proteins: Linking signaling networks and regulating transcription. Sci. Signal. 2008;1: doi: 10.1126/scisignal.133pe38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.133pe38</ArticleId><ArticleId IdType="pubmed">18714085</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa R., Biswas B., Mallick D., Ghosh A. Acute pancreatitis&#x2014;Complicating hepatitis E virus infection in a 7-year-old boy with glucose 6 phosphate dehydrogenase deficiency. Clin. Pediatr. 2009;48:199&#x2013;201. doi: 10.1177/0009922808327107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0009922808327107</ArticleId><ArticleId IdType="pubmed">19129425</ArticleId></ArticleIdList></Reference><Reference><Citation>Au W.Y., Ngai C.W., Chan W.M., Leung R.Y., Chan S.C. Hemolysis and methemoglobinemia due to hepatitis E virus infection in patient with G6PD deficiency. Ann. Hematol. 2011;90:1237&#x2013;1238. doi: 10.1007/s00277-011-1167-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-011-1167-6</ArticleId><ArticleId IdType="pmc">PMC3170118</ArticleId><ArticleId IdType="pubmed">21302113</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowinski A., Jablonska-Skwiecinska E., Wojda E., Bielen P., Ptak J., Sliwinski P., Gorecka D. Community-acquired pneumonia complications in a patient with hereditary glucose-6-phosphate dehydrogenase deficiency. Pneumonol. Alergol. Pol. 2007;75:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">17966106</ArticleId></ArticleIdList></Reference><Reference><Citation>Douzinas E.E., Flevari K., Andrianakis I., Betrosian A.P. Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency. Scand. J. Infect. Dis. 2010;42:76&#x2013;78. doi: 10.3109/00365540903321606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365540903321606</ArticleId><ArticleId IdType="pubmed">19883154</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos S.S., Brunialti M.K., Rigato O., Machado F.R., Silva E., Salomao R. Generation of nitric oxide and reactive oxygen species by neutrophils and monocytes from septic patients and association with outcomes. Shock. 2012;38:18&#x2013;23. doi: 10.1097/SHK.0b013e318257114e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318257114e</ArticleId><ArticleId IdType="pubmed">22575991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H.Y., Ho H.Y., Wu P.R., Chen S.H., Kuypers F.A., Cheng M.L., Chiu D.T. Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid. Redox Signal. 2015;22:744&#x2013;759. doi: 10.1089/ars.2014.6142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.6142</ArticleId><ArticleId IdType="pmc">PMC4361223</ArticleId><ArticleId IdType="pubmed">25556665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.C., Cheng M.L., Ho H.Y., Chiu D.T. The microbicidal and cytoregulatory roles of NADPH oxidases. Microbes Infect. Inst. Pasteur. 2011;13:109&#x2013;120. doi: 10.1016/j.micinf.2010.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.10.008</ArticleId><ArticleId IdType="pubmed">20971207</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpillon S., Floyd B.C., Gupte R.S., George S., Kozicky M., Neito V., Recchia F., Stanley W., Wolin M.S., Gupte S.A. Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. Am. J. Physiol. Heart Circ. Physiol. 2009;297:H153&#x2013;H162. doi: 10.1152/ajpheart.01142.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01142.2008</ArticleId><ArticleId IdType="pmc">PMC2711743</ArticleId><ArticleId IdType="pubmed">19429815</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupte R.S., Floyd B.C., Kozicky M., George S., Ungvari Z.I., Neito V., Wolin M.S., Gupte S.A. Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver. Free Radic. Biol. Med. 2009;47:219&#x2013;228. doi: 10.1016/j.freeradbiomed.2009.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.01.028</ArticleId><ArticleId IdType="pmc">PMC2700195</ArticleId><ArticleId IdType="pubmed">19230846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupte S.A. Glucose-6-phosphate dehydrogenase: A novel therapeutic target in cardiovascular diseases. Curr. Opin. Investig. Drugs. 2008;9:993&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">18729006</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton R.C. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012;64:362&#x2013;369. doi: 10.1002/iub.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1017</ArticleId><ArticleId IdType="pmc">PMC3325335</ArticleId><ArticleId IdType="pubmed">22431005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai K.J., Hung I.J., Chow C.K., Stern A., Chao S.S., Chiu D.T. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose 6-phosphate-dehydrogenase-deficient granulocytes. FEBS Lett. 1998;436:411&#x2013;414. doi: 10.1016/S0014-5793(98)01174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0014-5793(98)01174-0</ArticleId><ArticleId IdType="pubmed">9801159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M.L., Ho H.Y., Lin H.Y., Lai Y.C., Chiu D.T. Effective NET formation in neutrophils from individuals with G6PD Taiwan-Hakka is associated with enhanced NADP+ biosynthesis. Free Radic. Res. 2013;47:699&#x2013;709. doi: 10.3109/10715762.2013.816420.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715762.2013.816420</ArticleId><ArticleId IdType="pubmed">23777333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>